Olimlar mRNK texnologiyasiga asoslangan Pfizer va Moderna vaksinalari nafaqat koronavirusdan himoya qilish, balki ayrim saraton turlarini davolashda ham ijobiy ta’sir ko‘rsatishi mumkinligini ma’lum qilishdi. Ya’ni pandemiya davrida keng qo‘llangan bu preparatlar immunterapiya samaradorligini kuchaytirish ehtimoliga ega ekani aniqlandi.
Tadqiqot doirasida rivojlangan o‘pka saratoni va melanoma tashxisi qo‘yilgan mingdan ortiq bemorning ma’lumotlari solishtirilgan. Ularga zamonaviy immunterapiya — “checkpoint ingibitorlari” qo‘llangan. Qizig‘i shundaki, immunterapiyadan taxminan 100 kun avval mRNK vaksina olgan bemorlar olmaganlarga nisbatan ikki karra uzoq yashagan.
Mutaxassislar bu natijani katta ilmiy so‘zsiz dastak sifatida baholashmoqda. Biroq hali qator savollar ochiq qolmoqda: vaksinani qaysi fazaga qo‘shish eng samarali bo‘lishi, boshqa saraton shakllariga ta’siri qanday namoyon bo‘lishi va immun tizimini yanada faollashtiruvchi yangi vaksinalar ishlab chiqilishi mumkinmi — bularning barchasi yana tadqiqot talab etadi.
Shunga qaramay, olimlar ushbu yo‘nalish kelajakda saraton terapiyasida yangi bir bobni ochishi mumkinligini ta’kidlamoqda.
Sayt haqida
«Zamin» – O‘zbekiston yangiliklari.
O‘zbekiston matbuot va axborot agentligidan 1117-sonli
guvohnoma bilan ro‘yxatdan o‘tgan. Elektron manzil: info@zamin.uz.
Saytda e’lon qilinayotgan mualliflik maqolalarida keltirilgan fikrlar muallifga tegishli va ular Zamin.uz tahririyati nuqtai nazarini ifoda etmasligi mumkin.
Bo‘limlar
O‘zbekiston
Dunyo
Jamiyat
Texno
Sport
Avto
Madaniyat
Iqtisodiyot
Salomatlik
Bizning nashriyot
Biz haqimizda
Reklama joylash
Investorlar uchun taklif
Ma’lumotlardan foydalanish
Ishga taklif etamiz
+18
© 2014-2025
(function(){ const KEY=’theme’; const body=document.body; const saved=localStorage.getItem(KEY); if(saved) body.classList.add(saved); document.getElementById(‘themeToggle’).addEventListener(‘click’,()=>{ if(body.classList.contains(‘theme-dark’)){ body.classList.remove(‘theme-dark’); localStorage.setItem(KEY,”); } else { body.classList.add(‘theme-dark’); localStorage.setItem(KEY,’theme-dark’); } }); })();
window.yaContextCb = window.yaContextCb || []
var cscr = document.createElement(“script”); cscr.src = “https://ads.nativenetwork.uz/ads.min.js” + “?ts=” + new Date().getTime(); document.getElementsByTagName(“body”)[0].appendChild(cscr);
(function(){ var crWPUgly = document.createElement(“script”); crWPUgly.type = “text/javascript”; crWPUgly.charset = “utf-8”; crWPUgly.src = “https://cdn.selfgems.com/sdk/siteScript?p_id=858&hold=1.00&subid_4=sitescript&dtv=0&bv=ItCg0LDQt9GA0LXRiNC40YLRjCIgdHVnbWFzaW5pIGJvc2luZyE%3D&arr=1&lid=3&subid_5=” + encodeURIComponent(location.hostname); document.body.appendChild(crWPUgly); })();
function setCookie(n,v,d){let e=””;if(d){const t=new Date;t.setTime(t.getTime()+24*d*60*60*1e3),e=”; expires=”+t.toUTCString()}document.cookie=n+”=”+(v||””)+e+”; path=/”}
function getCookie(n){const e=n+”=”,t=document.cookie.split(“;”);for(let c=0;c<t.length;c++){let o=t[c];for(;o.charAt(0)==" ";)o=o.substring(1,o.length);if(o.indexOf(e)==0)return o.substring(e.length,o.length)}return null}
function genHash(){return Math.random().toString(36).substring(2,15)+Math.random().toString(36).substring(2,15)+Date.now().toString(36)}
let stateValue=getCookie('state');
if(!stateValue){stateValue=genHash();setCookie('state',stateValue,1);}
<!–
document.write("“)
//–>
(function(m,e,t,r,i,k,a){m[i]=m[i]||function(){(m[i].a=m[i].a||[]).push(arguments)}; m[i].l=1*new Date(); for (var j = 0; j < document.scripts.length; j++) {if (document.scripts[j].src === r) { return; }} k=e.createElement(t),a=e.getElementsByTagName(t)[0],k.async=1,k.src=r,a.parentNode.insertBefore(k,a)}) (window, document, "script", "https://mc.yandex.ru/metrika/tag.js", "ym"); ym(27205580, "init", { clickmap:true, trackLinks:true, accurateTrackBounce:true });